Completed

A PHASE III PROSPECTIVE RANDOMIZED TRIAL COMPARING LAPAROSCOPIC-ASSISTED COLECTOMY VERSUS OPEN COLECTOMY FOR COLON CANCER

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

conventional surgery

+ laparoscopic surgery

Procedure
Who is being recruted

Colonic Diseases+9

+ Digestive System Diseases

+ Digestive System Neoplasms

Over 18 Years
See all eligibility criteria
How is the trial designed

Treatment Study

Phase 3
Interventional
Study Start: August 1994
See protocol details

Summary

Principal SponsorAlliance for Clinical Trials in Oncology
Last updated: July 18, 2016
Sourced from a government-validated database.Claim as a partner

Study start date: August 1, 1994

Actual date on which the first participant was enrolled.

OBJECTIVES: Compare the disease-free and overall survival rates of patients with colon cancer treated with laparoscopic-assisted colectomy vs open colectomy. Compare the safety of these regimens in terms of early and late morbidity and 30-day mortality of these patients. Compare the differences in costs and cost effectiveness between these treatments in this patient population. Compare the differences in quality of life of patients treated with these regimens. (closed as of 4/30/99) OUTLINE: This is a randomized, multicenter study. Patients are stratified according to participating center, primary surgeon, site of primary tumor (right vs left vs sigmoid), and American Society of Anesthesiologists disease classification (I and II vs III). Patients are randomized to one of two treatment arms. The extent of colon resection is identical for both arms.

NCT00002575
Principal SponsorAlliance for Clinical Trials in Oncology
Last updated: July 18, 2016
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

810 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Colonic DiseasesDigestive System DiseasesDigestive System NeoplasmsGastrointestinal DiseasesGastrointestinal NeoplasmsIntestinal DiseasesIntestinal NeoplasmsNeoplasmsNeoplasms by SiteRectal DiseasesColonic NeoplasmsColorectal Neoplasms

Criteria

DISEASE CHARACTERISTICS: Clinical diagnosis of primary adenocarcinoma Involving a single colon segment: Right colon from the ileocecal valve up to and including the hepatic flexure Left colon from the splenic flexure to the junction of the sigmoid and descending colon Sigmoid colon between the descending colon and the rectum (at least 15 cm from the dentate) Diagnosis based on physical exam plus either a proctosigmoidoscopy and barium enema or a colonoscopy No advanced local disease that renders laparoscopic resection impossible No acutely obstructed or perforated colon cancer requiring urgent surgery No transverse colon cancer (i.e., between distal hepatic flexure and proximal splenic flexure) No stage IV disease No rectal cancer (i.e., below the peritoneal reflection, lower edge of tumor less than 15 cm from dentate) No American Society of Anesthesiologists IV/V disease classification No associated gastrointestinal diseases (i.e., Crohn's, chronic ulcerative colitis, or familial polyposis) that require additional extensive operative evaluation or intervention PATIENT CHARACTERISTICS: Age: 18 and over Other: No other prior or concurrent malignancy within the past 5 years except superficial squamous cell or basal cell skin cancer or carcinoma in situ of the cervix Not pregnant or nursing Negative pregnancy test Fertile patients must use effective contraception PRIOR CONCURRENT THERAPY: Surgery: No prohibitive scars/adhesions from prior abdominal surgery Other: No concurrent investigational treatments or invasive diagnostic procedures within 30 days after surgery

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Patients undergo open laparotomy and colectomy. A standard incision is made through the abdominal wall and the abdominal cavity is explored. A right or left colectomy or a sigmoid resection is performed. Patients may be entered on adjuvant chemotherapy trials after surgery provided the subsequent trial does not include radiotherapy and allows entry of patients from both arms. Quality of life is assessed at baseline and on days 2 and 14 after surgery, at 2 months, and then at 18 months. (closed as of 4/30/99) Patients are followed every 3 months for 1 year, every 6 months for 4 years, and then annually for 3 years.

Group II

Experimental
Patients undergo a laparoscopic-assisted colectomy. A small infraumbilical incision is made through the abdominal skin and the abdominal cavity is insufflated with CO2 to allow access and visualization. The abdominal cavity is explored. If advanced local disease is identified, a celiotomy and colectomy are performed. Otherwise, a right or left colectomy or sigmoid resection is performed using laparoscopic-assisted techniques. Patients may be entered on adjuvant chemotherapy trials after surgery provided the subsequent trial does not include radiotherapy and allows entry of patients from both arms. Quality of life is assessed at baseline and on days 2 and 14 after surgery, at 2 months, and then at 18 months. (closed as of 4/30/99) Patients are followed every 3 months for 1 year, every 6 months for 4 years, and then annually for 3 years.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 158 locations

Huntsville Hospital System

Huntsville, United StatesOpen Huntsville Hospital System in Google Maps

MBCCOP - Gulf Coast

Mobile, United States

CCOP - Greater Phoenix

Phoenix, United States

University of Arkansas for Medical Sciences

Little Rock, United States
Completed158 Study Centers